ATE345782T1 - Dosierungsformen enthaltend geschmacksmaskierten wirkstoffen - Google Patents

Dosierungsformen enthaltend geschmacksmaskierten wirkstoffen

Info

Publication number
ATE345782T1
ATE345782T1 AT99971312T AT99971312T ATE345782T1 AT E345782 T1 ATE345782 T1 AT E345782T1 AT 99971312 T AT99971312 T AT 99971312T AT 99971312 T AT99971312 T AT 99971312T AT E345782 T1 ATE345782 T1 AT E345782T1
Authority
AT
Austria
Prior art keywords
dosage forms
active ingredients
forms containing
containing flavor
masked active
Prior art date
Application number
AT99971312T
Other languages
English (en)
Inventor
Djelila Mezaache
Michael G Raiden
Pradeepkumar P Sanghvi
Scott J Szedlock
Original Assignee
Biovail Tech Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biovail Tech Ltd filed Critical Biovail Tech Ltd
Application granted granted Critical
Publication of ATE345782T1 publication Critical patent/ATE345782T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT99971312T 1998-10-30 1999-10-26 Dosierungsformen enthaltend geschmacksmaskierten wirkstoffen ATE345782T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/183,501 US6165512A (en) 1998-10-30 1998-10-30 Dosage forms containing taste masked active agents

Publications (1)

Publication Number Publication Date
ATE345782T1 true ATE345782T1 (de) 2006-12-15

Family

ID=22673073

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99971312T ATE345782T1 (de) 1998-10-30 1999-10-26 Dosierungsformen enthaltend geschmacksmaskierten wirkstoffen

Country Status (8)

Country Link
US (1) US6165512A (de)
EP (1) EP1124540B1 (de)
AT (1) ATE345782T1 (de)
AU (1) AU1232600A (de)
CA (1) CA2348451C (de)
DE (1) DE69934135T2 (de)
ES (1) ES2278466T3 (de)
WO (1) WO2000025755A1 (de)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6057139A (en) 1995-06-29 2000-05-02 Mcneil-Ppc, Inc. Preblend of microcrystalline cellulose and lactase for making tablets
DE19646392A1 (de) * 1996-11-11 1998-05-14 Lohmann Therapie Syst Lts Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht
US7815937B2 (en) * 1998-10-27 2010-10-19 Biovail Laboratories International Srl Quick dissolve compositions and tablets based thereon
WO2000024380A1 (en) * 1998-10-27 2000-05-04 Fuisz Technologies Ltd. Microparticles containing peg and/or peg glyceryl esters
EP1179342B1 (de) * 1999-05-21 2006-03-29 Kissei Pharmaceutical Co., Ltd. Medizinische zusammensetzungen zur unmittelbaren freisetzung bei oraler anwendung
DE19940740A1 (de) * 1999-08-31 2001-03-01 Gruenenthal Gmbh Pharmazeutische Salze
DE60218822T2 (de) * 2001-02-09 2007-07-12 Unilever N.V. Nahrungsmittel enthaltend sojaprotein und statin
EP1367999A4 (de) * 2001-02-16 2007-04-18 Lavipharm Lab Inc Wasserlösliche komplexe mit angenehmem geschmack
CN1335182A (zh) * 2001-08-08 2002-02-13 华中科技大学 胰岛素口腔喷剂及其制备工艺
US7323192B2 (en) * 2001-09-28 2008-01-29 Mcneil-Ppc, Inc. Immediate release tablet
US7122143B2 (en) 2001-09-28 2006-10-17 Mcneil-Ppc, Inc. Methods for manufacturing dosage forms
US20040213848A1 (en) 2001-09-28 2004-10-28 Shun-Por Li Modified release dosage forms
US7838026B2 (en) 2001-09-28 2010-11-23 Mcneil-Ppc, Inc. Burst-release polymer composition and dosage forms comprising the same
EP1941878A1 (de) 2002-01-10 2008-07-09 Biovail Laboratories International Srl Sedative Formulierungen ohne Benzodiazepin
WO2003072021A2 (en) * 2002-02-06 2003-09-04 King Pharmaceuticals, Inc. Oral pediatric trimethobenzamide formulations and methods
US20070087981A1 (en) * 2002-02-08 2007-04-19 Lavipharm Laboratories, Inc. Water Soluble and Palatable Complexes
US7807197B2 (en) 2002-09-28 2010-10-05 Mcneil-Ppc, Inc. Composite dosage forms having an inlaid portion
US6689343B1 (en) * 2002-11-05 2004-02-10 Ultradent Products, Inc. Hemostatic and acid etch compositions containing sucralose
BRPI0416534A (pt) 2003-12-04 2007-01-09 Pfizer Prod Inc composições multiparticuladas com estabilidade melhorada
ATE399536T1 (de) 2003-12-04 2008-07-15 Pfizer Prod Inc Verfahren zur herstellung von pharmazeutischen multiteilchenförmigen produkten
US6984403B2 (en) 2003-12-04 2006-01-10 Pfizer Inc. Azithromycin dosage forms with reduced side effects
WO2005053652A1 (en) 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride
BRPI0417348A (pt) 2003-12-04 2007-03-13 Pfizer Prod Inc processo de gelatinização por spray com utilização de uma extrusora para preparação de composições de droga cristalina multiparticulada contendo preferencialmente um poloxámero e um glicerìdeo
US20050136112A1 (en) * 2003-12-19 2005-06-23 Pediamed Pharmaceuticals, Inc. Oral medicament delivery system
GB0400452D0 (en) * 2004-01-09 2004-02-11 Norton Healthcare Ltd A pharmaceutical composition
EP1621187A1 (de) * 2004-07-26 2006-02-01 AstraZeneca AB Pharmazeutische multipartikuläre Tablettenzubereitungen und Prozess zu ihrer Herstellung
US20060039966A1 (en) * 2004-08-12 2006-02-23 Miller Bruce A Jr Dosage delivery apparatus for improving user acceptance of oral supplements and medicaments and methods for manufacturing same
EP1640401A3 (de) * 2004-09-24 2006-04-12 Clariant Produkte (Deutschland) GmbH Polyethylenglykol und Alkoholethoxylate und deren Herstellung
US7611695B2 (en) * 2004-11-15 2009-11-03 Ultradent Products, Inc. Flavored hemostatic and acid etching compositions
US20070020330A1 (en) 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
ES2704482T3 (es) 2004-11-24 2019-03-18 Meda Pharmaceuticals Inc Composiciones que comprenden azelastina y sus métodos de uso
US8758816B2 (en) 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
US8673352B2 (en) 2005-04-15 2014-03-18 Mcneil-Ppc, Inc. Modified release dosage form
US7811604B1 (en) 2005-11-14 2010-10-12 Barr Laboratories, Inc. Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine and methods of making and using the same
US20070134277A1 (en) * 2005-12-09 2007-06-14 Children's Medical Center Corporation Pharmaceutical formulation for sulfur-containing drugs in liquid dosage forms
EP1935405A1 (de) * 2006-12-22 2008-06-25 LEK Pharmaceuticals D.D. Im Mund zerfallende Tabletten
WO2008109018A1 (en) * 2007-03-02 2008-09-12 Meda Pharmaceuticals Inc. Compositions comprising carisoprodol and methods of use thereof
EP2389155A2 (de) * 2009-01-16 2011-11-30 ADD Technologies Ltd. Im mund zerfallende tabletten zur behandlung von schmerzen
US8952038B2 (en) 2010-03-26 2015-02-10 Philip Morris Usa Inc. Inhibition of undesired sensory effects by the compound camphor
RU2573293C2 (ru) 2010-03-26 2016-01-20 Филип Моррис Продактс С.А. Ингибирование раздражающих ощущений при потреблении некурительных табачных продуктов
BR112013006381B1 (pt) * 2010-09-20 2024-02-15 Spi Pharma Inc Composição que compreende um material de núcleo tendo um valor de sabor e um revestimento polimérico e formulação farmacêutica
FI126168B (en) 2012-09-18 2016-07-29 Novaldmedical Ltd Oy A method for coating pharmaceutical substrates
US9662345B2 (en) 2013-06-14 2017-05-30 Professional Compounding Centers Of America Antibiotic composition for inhalation and irrigation
EP3061501A1 (de) 2015-02-27 2016-08-31 Rottapharm Ltd. Zusammensetzung zur behandlung von akne
EP3288556A4 (de) 2015-04-29 2018-09-19 Dexcel Pharma Technologies Ltd. Oral zerfallende zusammensetzungen
EP3302104B1 (de) * 2015-06-04 2020-09-30 Balchem Corporation Hydrierungssteuerung für cholinsalze
ES2968237T3 (es) * 2015-07-09 2024-05-08 Uniwell Laboratories Llc Composiciones farmacéuticas
EP3117825A1 (de) 2015-07-16 2017-01-18 Rottapharm S.p.A. Orale formulierung mit berberin und morus-alba-extrakt
CN115381792A (zh) * 2015-10-02 2022-11-25 帝斯曼知识产权资产管理有限公司 新颖的包衣体系
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
EP3740197A4 (de) 2018-01-16 2021-11-10 Applied Materials, Inc. Metalloxidverkapselte wirkstoffzusammensetzungen und verfahren zu ihrer herstellung

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5387431A (en) * 1991-10-25 1995-02-07 Fuisz Technologies Ltd. Saccharide-based matrix
ATE130195T1 (de) * 1988-07-26 1995-12-15 Univ Rutgers Vorrichtungen und verfahren zur wachstumsförderung bei bratgeflügel.
WO1992009275A1 (en) * 1990-11-30 1992-06-11 Yamanouchi Pharmaceutical Co., Ltd. Quick release coated preparation
CA2095776C (en) * 1992-05-12 2007-07-10 Richard C. Fuisz Rapidly dispersable compositions containing polydextrose
US5895664A (en) * 1993-09-10 1999-04-20 Fuisz Technologies Ltd. Process for forming quickly dispersing comestible unit and product therefrom
US5518551A (en) * 1993-09-10 1996-05-21 Fuisz Technologies Ltd. Spheroidal crystal sugar and method of making
DE69527711T2 (de) * 1994-06-14 2002-12-05 Biovail Tech Ltd Verfahren und apparat zur herstellung von schnelllöslichen dosierungseinheiten und daraus erhältliches produkt
US5458823A (en) * 1994-10-28 1995-10-17 Fuisz Technologies Ltd. Method and apparatus for spinning feedstock material
US5683720A (en) * 1994-10-28 1997-11-04 Fuisz Technologies Ltd. Liquiflash particles and method of making same
US5834033A (en) * 1997-05-12 1998-11-10 Fuisz Technologies Ltd. Apparatus for melt spinning feedstock material having a flow restricting ring
US5851454A (en) * 1997-06-13 1998-12-22 Fuisz Technologies, Ltd. Spinner head having flow restricting inserts
US5869098A (en) * 1997-08-20 1999-02-09 Fuisz Technologies Ltd. Fast-dissolving comestible units formed under high-speed/high-pressure conditions

Also Published As

Publication number Publication date
DE69934135T2 (de) 2007-07-26
AU1232600A (en) 2000-05-22
ES2278466T3 (es) 2007-08-01
EP1124540B1 (de) 2006-11-22
CA2348451A1 (en) 2000-05-11
CA2348451C (en) 2009-01-27
WO2000025755A1 (en) 2000-05-11
EP1124540A1 (de) 2001-08-22
US6165512A (en) 2000-12-26
DE69934135D1 (de) 2007-01-04

Similar Documents

Publication Publication Date Title
ATE345782T1 (de) Dosierungsformen enthaltend geschmacksmaskierten wirkstoffen
AR026745A1 (es) Composiciones de eplerenona nanoparticulada
BG104693A (en) Fast melting oral dosage form
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
MY125651A (en) Eplerenone compositions
DE69936393D1 (de) Behandlung akuter gesundheitsstörungen durch die sublingual verabreichung einer pharmazeutischen zusammensetzung
HUP0301349A2 (hu) IL-11-tartalmú készítmények
DE60022180D1 (de) Dentales produkt gegen zahnstein und betreffende methode
HUP0201877A2 (hu) Hal zselatint tartalmazó, gyorsan diszpergálódó dózis formák
TR200100172T2 (tr) Oral katı doz formunda eprosartan içeren biyolojik bakımdan kuvvetlendirilmiş formülasyonlar
WO2002045684A3 (en) Rapidly dispersing pharmaceutical composition comprising effervescent agents
NZ331705A (en) Immediate release ph-independent solid dosage form of cisapride
HK1070836A1 (en) Solid oral anti-tartar and anti-plaque compositions
SE0102843D0 (sv) Stabilized oral pharmaceutical composition containing lodide and lodate and method
HUP0002490A2 (hu) Csersav-polimer kompozíciók gyógyászati anyagok szabályozott leadására, különösen a szájüregben
HUP0402142A2 (hu) Kombinációs ösztrogén-gestagen készítmény és alkalmazása
HUP0103216A2 (hu) Gasztrointesztinális hatóanyagokat tartalmazó mukoadhezív készítmények
MY127350A (en) Flash-melt oral dose formulations
EP1123696A4 (de) Zubereitungen für die mundhöhle
IL141236A0 (en) New oral formulations for 5-ht4 agonists or antagonists
BG103005A (en) Active substance-containing sedimented silicic acids
HUP0402178A2 (hu) 5 HT1 antagonista hatóanyagot tartalmazó gyógyszerkészítmény
HUP0303178A2 (hu) Eljárások és készítmények gyógyászatilag aktív anyagok ízének csökkentésére
ATE370724T1 (de) Mundpflegemittel enthaltend einen fluor-ion- vektor und ein antioxidationsmittel
MY152490A (en) New oral formulation

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties